Amedisys, Inc.
- Jurisdiction
United States - LEI
5299001RBS9GK9STN379 - ISIN
US0234361089 (AMED )- Sectors
Scores
- Fair value (Benjamin Graham formula)
-
€111.72 29.2% undervalued - Financial strength (Piotroski F-Value)
-
9
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
4
/ 7
Profile
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. Read full profile
Fundamentals
- Net revenue
€2.05B - Gross margin
52.3% - EBIT
€84.99M - EBIT margin
4.1% - Net income
€127.68M - Net margin
6.2%
Statement period: - (published )
Estimates
| Fiscal Year | Net revenue | Net income |
|---|---|---|
|
|
| |
|
|
| |
| N/A | N/A |
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions
Congress transactions
| Name | Transaction date | Value |
|---|---|---|
| Lisa McClain | September 12, 2025 | $1.00K–$15.00K |
| Lisa McClain | August 13, 2025 | $1.00K–$15.00K |
Investor transactions
| Name | Shares | Value | Last change | Change type |
|---|---|---|---|---|
| Peter Brown |
|
|
|
Sell |